Log In
BCIQ
Print this Print this
 

IMU-366

  Manage Alerts
Collapse Summary General Information
Company Immunic AG
DescriptionOrally available RORgammaT inhibitor
Molecular Target RAR-related orphan receptor C (RORC) (RORgamma)
Mechanism of ActionRAR-related orphan receptor (ROR) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPsoriasis
Indication DetailsTreat psoriasis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today